The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Crohn’s Disease Therapeutics Market Research Report 2024
Synopsis
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
The global Crohn’s Disease Therapeutics market was valued at US$ 3320.3 million in 2023 and is anticipated to reach US$ 3764.2 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Therapeutics.
Report Scope
The Crohn’s Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crohn’s Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn’s Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Segment by Type
Non-Surgical
Surgical
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn’s Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
The global Crohn’s Disease Therapeutics market was valued at US$ 3320.3 million in 2023 and is anticipated to reach US$ 3764.2 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Therapeutics.
Report Scope
The Crohn’s Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crohn’s Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn’s Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Segment by Type
Non-Surgical
Surgical
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn’s Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-Surgical
1.2.3 Surgical
1.3 Market by Application
1.3.1 Global Crohn’s Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Therapeutics Market Perspective (2019-2030)
2.2 Crohn’s Disease Therapeutics Growth Trends by Region
2.2.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Crohn’s Disease Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Crohn’s Disease Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Crohn’s Disease Therapeutics Market Dynamics
2.3.1 Crohn’s Disease Therapeutics Industry Trends
2.3.2 Crohn’s Disease Therapeutics Market Drivers
2.3.3 Crohn’s Disease Therapeutics Market Challenges
2.3.4 Crohn’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Therapeutics Players by Revenue
3.1.1 Global Top Crohn’s Disease Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Crohn’s Disease Therapeutics Revenue
3.4 Global Crohn’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Therapeutics Revenue in 2023
3.5 Crohn’s Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Crohn’s Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Crohn’s Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Therapeutics Breakdown Data by Type
4.1 Global Crohn’s Disease Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2025-2030)
5 Crohn’s Disease Therapeutics Breakdown Data by Application
5.1 Global Crohn’s Disease Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Crohn’s Disease Therapeutics Market Size (2019-2030)
6.2 North America Crohn’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Crohn’s Disease Therapeutics Market Size by Country (2019-2024)
6.4 North America Crohn’s Disease Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn’s Disease Therapeutics Market Size (2019-2030)
7.2 Europe Crohn’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Crohn’s Disease Therapeutics Market Size by Country (2019-2024)
7.4 Europe Crohn’s Disease Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Crohn’s Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Therapeutics Market Size (2019-2030)
9.2 Latin America Crohn’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Crohn’s Disease Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Crohn’s Disease Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Crohn’s Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson Services Inc.
11.1.1 Johnson and Johnson Services Inc. Company Detail
11.1.2 Johnson and Johnson Services Inc. Business Overview
11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
11.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.1.5 Johnson and Johnson Services Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
11.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.2.5 Pfizer Inc. Recent Development
11.3 Allergan
11.3.1 Allergan Company Detail
11.3.2 Allergan Business Overview
11.3.3 Allergan Crohn’s Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.3.5 Allergan Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Detail
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
11.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.4.5 AbbVie Inc. Recent Development
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Detail
11.5.2 Takeda Pharmaceutical Company Limited Business Overview
11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.5.5 Takeda Pharmaceutical Company Limited Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Detail
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
11.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.6.5 Celgene Corporation Recent Development
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Detail
11.7.2 Perrigo Company PLC Business Overview
11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
11.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.7.5 Perrigo Company PLC Recent Development
11.8 Ferring B.V.
11.8.1 Ferring B.V. Company Detail
11.8.2 Ferring B.V. Business Overview
11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
11.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.8.5 Ferring B.V. Recent Development
11.9 Salix Pharmaceuticals
11.9.1 Salix Pharmaceuticals Company Detail
11.9.2 Salix Pharmaceuticals Business Overview
11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
11.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.9.5 Salix Pharmaceuticals Recent Development
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Detail
11.10.2 Gilead Sciences Inc. Business Overview
11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
11.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.10.5 Gilead Sciences Inc. Recent Development
11.11 Genentech Inc.
11.11.1 Genentech Inc. Company Detail
11.11.2 Genentech Inc. Business Overview
11.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
11.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.11.5 Genentech Inc. Recent Development
11.12 UCB India Private Limited.
11.12.1 UCB India Private Limited. Company Detail
11.12.2 UCB India Private Limited. Business Overview
11.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
11.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2019-2024)
11.12.5 UCB India Private Limited. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
